Patrick Forde, Professor at The Johns Hopkins University, shared on X:
“Published in today’s print edition of NEJM the final survival results of neoadjuvant nivo in lung cancer along with a 2 min quick take video & an elegant editorial from Dr. Virginia Calvo.”
Title: Neoadjuvant Nivolumab in Resectable Lung Cancer
More posts featuring Lung Cancer.